Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 815621, 22 pages
http://dx.doi.org/10.1155/2013/815621
Review Article

An Update on Antitumor Activity of Naturally Occurring Chalcones

1School of Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100102, China
2School of Preclinical Medicine, Beijing University of Chinese Medicine, Beijing 100029, China

Received 15 January 2013; Accepted 19 March 2013

Academic Editor: Yoshiyuki Kimura

Copyright © 2013 En-Hui Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. R. Yadav, S. Prasad, B. Sung, and B. B. Aggarwal, “The role of chalcones in suppression of NF-κB-mediated inflammation and cancer,” International Immunopharmacology, vol. 11, no. 3, pp. 295–309, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. S. V. Kostanecki and J. Tabor, “Ueber die sechs isomeren Monooxybenzalacetophenone (Monooxychalkone),” Berichte Der Deutschen Chemischen Gesellschaft, vol. 32, no. 2, pp. 1921–1926, 1899. View at Google Scholar
  3. Ø. M. Andersen and K. R. Markham, FLAVONOIDS: Chemistry, Biochemistry and Applications, CRC Press, 2006.
  4. S. A. Chowdhury, K. Kishino, R. Satoh et al., “Tumor-specificity and apoptosis-inducing activity of stilbenes and flavonoids,” Anticancer Research, vol. 25, no. 3 B, pp. 2055–2063, 2005. View at Google Scholar · View at Scopus
  5. S. N. A. Malek, C. W. Phang, H. Ibrahim, N. A. Wahab, and K. S. Sim, “Phytochemical and cytotoxic investigations of Alpinia mutica rhizomes,” Molecules, vol. 16, no. 1, pp. 583–589, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. X. Zi and A. R. Simoneau, “Flavokawain A, a novel chalcone from kava extract, induces apoptosis in bladder cancer cells by involvement of Bax protein-dependent and mitochondria-dependent apoptotic pathway and tumor growth in mice,” Cancer Research, vol. 65, no. 8, pp. 3479–3486, 2005. View at Google Scholar · View at Scopus
  7. N. W. Nwet, S. Awale, H. Esumi, Y. Tezuka, and S. Kadota, “Bioactive secondary metabolites from Boesenbergia pandurata of Myanmar and their preferential cytotoxicity against human pancreatic cancer PANC-1 cell line in nutrient-deprived medium,” Journal of Natural Products, vol. 70, no. 10, pp. 1582–1587, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Chen, Y. Li, L. Q. Yang, Y. Z. Li, Z. B. Nan, and K. Gao, “Biological activities of flavonoids from pathogenic-infected Astragalus adsurgens,” Food Chemistry, vol. 131, no. 2, pp. 546–551, 2012. View at Google Scholar
  9. C. L. Ye, J. W. Liu, D. Z. Wei, Y. H. Lu, and F. Qian, “In vitro anti-tumor activity of 2′,4′-dihydroxy-6′- methoxy-3′,5′-dimethylchalcone against six established human cancer cell lines,” Pharmacological Research, vol. 50, no. 5, pp. 505–510, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. E. C. Amor, I. M. Villaseñor, R. Antemano, Z. Perveen, G. P. Concepcion, and M. I. Choudhary, “Cytotoxic C-methylated chalcones from Syzygium samarangense,” Pharmaceutical Biology, vol. 45, no. 10, pp. 777–783, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. M. J. Simirgiotis, S. Adachi, S. To et al., “Cytotoxic chalcones and antioxidants from the fruits of Syzygium samarangense (Wax Jambu),” Food Chemistry, vol. 107, no. 2, pp. 813–819, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Li, S. Awale, Y. Tezuka, and S. Kadota, “Cytotoxic constituents from Brazilian red propolis and their structure-activity relationship,” Bioorganic and Medicinal Chemistry, vol. 16, no. 10, pp. 5434–5440, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. X. Yu, W. Wang, and M. Yang, “Antioxidant activities of compounds isolated from Dalbergia odorifera T. Chen and their inhibition effects on the decrease of glutathione level of rat lens induced by UV irradiation,” Food Chemistry, vol. 104, no. 2, pp. 715–720, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Yoon, Y. D. Jung, and S. H. Cheon, “Cytotoxic allyl retrochalcone from the roots of Glycyrrhiza inflata,” Chemical and Pharmaceutical Bulletin, vol. 53, no. 6, pp. 694–695, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. M. C. Li, Z. Yao, Y. Takaishi, S. A. Tang, and H. Q. Duan, “Isolation of novel phenolic compounds with multidrug resistance (MDR) reversal properties from Onychium japonicum,” Chemistry and Biodiversity, vol. 8, no. 6, pp. 1112–1120, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. U. Prawat, D. Phupornprasert, A. Butsuri, A. W. Salae, S. Boonsri, and P. Tuntiwachwuttikul, “Flavonoids from Friesodielsia discolor,” Phytochemistry Letters, vol. 5, no. 4, pp. 809–813, 2012. View at Google Scholar
  17. L. Cui, T. T. Phuong, S. L. Hyun et al., “Four new chalcones from Erythrina abyssinica,” Planta Medica, vol. 74, no. 4, pp. 422–426, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. W. S. Wang, Y. W. Zhou, Y. H. Ye, and M. L. Li, “A novel prenylchalcone from Humulus lupulus,” Chinese Chemical Letters, vol. 15, no. 10, pp. 1195–1196, 2004. View at Google Scholar · View at Scopus
  19. S. Vogel and J. Heilmann, “Synthesis, cytotoxicity, and antioxidative activity of minor prenylated chalcones from Humulus lupulus,” Journal of Natural Products, vol. 71, no. 7, pp. 1237–1241, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Vogel, S. Ohmayer, G. Brunner, and J. Heilmann, “Natural and non-natural prenylated chalcones: synthesis, cytotoxicity and anti-oxidative activity,” Bioorganic and Medicinal Chemistry, vol. 16, no. 8, pp. 4286–4293, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Delmulle, A. Bellahcène, W. Dhooge et al., “Anti-proliferative properties of prenylated flavonoids from hops (Humulus lupulus L.) in human prostate cancer cell lines,” Phytomedicine, vol. 13, no. 9-10, pp. 732–734, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. H. L. Jae, N. I. Baek, S. H. Kim et al., “A new cytotoxic prenylated chalcone from Sophora flavescens,” Archives of Pharmacal Research, vol. 30, no. 4, pp. 408–411, 2007. View at Google Scholar · View at Scopus
  23. C. C. Shen, T. W. Lin, Y. L. Huang, S. T. Wan, B. J. Shien, and C. C. Chen, “Phenolic constituents of the roots of Sophora flavescens,” Journal of Natural Products, vol. 69, no. 8, pp. 1237–1240, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. X. H. Su, C. Y. Li, Y. J. Zhong, Z. P. Yuan, Y. F. Li, and B. Liang, “A new prenylated chalcone from the seeds of Millettia pachycarpa,” Chinese Journal of Natural Medicines, vol. 10, no. 3, pp. 222–225, 2012. View at Google Scholar
  25. H. Ye, A. Fu, W. Wu et al., “Cytotoxic and apoptotic effects of constituents from Millettia pachycarpa Benth,” Fitoterapia, vol. 83, no. 8, pp. 1402–1408, 2012. View at Google Scholar
  26. S. C. Fang, C. L. Hsu, Y. S. Yu, and G. C. Yen, “Cytotoxic effects of new geranyl chalcone derivatives isolated from the leaves of Artocarpus communis in SW 872 human liposarcoma cells,” Journal of Agricultural and Food Chemistry, vol. 56, no. 19, pp. 8859–8868, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Borges-Argáez, L. Balnbury, A. Flowers et al., “Cytotoxic and antiprotozoal activity of flavonoids from Lonchocarpus spp,” Phytomedicine, vol. 14, no. 7-8, pp. 530–533, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. G. M. De Andrade Cunha, J. B. Fontenele, H. V. Nobre Júnior et al., “Cytotoxic activity of chalcones isolated from lonchocarpus sericeus (Pocr.) Kunth,” Phytotherapy Research, vol. 17, no. 2, pp. 155–159, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Kang, M. A. Park, M. Y. Cho, K. H. Lee, and J. A. Kim, “Cytotoxic effect of chalcone derivatives in MCF-7 human breast cancer and HT-1080 human fibrosarcoma cells,” Yakhak Hoechi, vol. 54, no. 1, pp. 27–31, 2010. View at Google Scholar
  30. S. Takaoka, H. Hibasami, K. Ogasawara, and N. Imai, “Chalcones from Angelica keiskei induce apoptosis in stomach cancer cells,” Journal of Herbs, Spices and Medicinal Plants, vol. 14, no. 3-4, pp. 166–174, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. Q. J. Zhang, Y. B. Tang, R. Y. Chen, and D. Q. Yu, “Three new cytotoxic Diels-Alder-type adducts from Morus australis,” Chemistry and Biodiversity, vol. 4, no. 7, pp. 1533–1540, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. X. Q. Cui, L. Wang, R. Y. Yan, Y. X. Tan, R. Y. Chen, and D. Q. Yu, “A new Diels-Alder type adduct and two new flavones from the stem bark of Morus yunanensis Koidz,” Journal of Asian Natural Products Research, vol. 10, no. 4, pp. 315–318, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. M. C. Li, Z. Yao, Y. W. Zhang, Y. Takaishi, and H. Q. Duan, “A novel chalcone derivative from Onychium japonicum,” Chinese Chemical Letters, vol. 18, no. 7, pp. 840–842, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. L. Wirasathien, T. Pengsuparp, M. Moriyasu, K. Kawanishi, and R. Suttisri, “Cytotoxic C-benzylated chalcone and other constituents of Ellipeiopsis cherrevensis,” Archives of Pharmacal Research, vol. 29, no. 6, pp. 497–502, 2006. View at Google Scholar · View at Scopus
  35. L. K. Mdee, S. O. Yeboah, and B. M. Abegaz, “Rhuschalcones II-VI, five new bichalcones from the root bark of Rhus pyroides,” Journal of Natural Products, vol. 66, no. 5, pp. 599–604, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. M. O. Hengartner, “The biochemistry of apoptosis,” Nature, vol. 407, no. 6805, pp. 770–776, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. W. R. Sellers and D. E. Fisher, “Apoptosis and cancer drug targeting,” Journal of Clinical Investigation, vol. 104, no. 12, pp. 1655–1661, 1999. View at Google Scholar · View at Scopus
  38. A. Chiarugi and M. A. Moskowitz, “Cell biology: PARP-1: a perpetrator of apoptotic cell death?” Science, vol. 297, no. 5579, pp. 200–201, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. K. Tabata, K. Motani, N. Takayanagi et al., “Xanthoangelol, a major chalcone constituent of Angelica keiskei, induces apoptosis in neuroblastoma and leukemia cells,” Biological and Pharmaceutical Bulletin, vol. 28, no. 8, pp. 1404–1407, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. J. M. Yun, H. Kwon, H. Mukhtar, and J. K. Hwang, “Induction of apoptosis by panduratin A isolated from Kaempferia pandurata in human colon cancer HT-29 cells,” Planta Medica, vol. 71, no. 6, pp. 501–507, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Thorburn, K. Behbakht, and H. Ford, “TRAIL receptor-targeted therapeutics: resistance mechanisms and strategies to avoid them,” Drug Resistance Updates, vol. 11, no. 1-2, pp. 17–24, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. E. Szliszka and W. Krol, “The role of dietary polyphenols in tumor necrosis factor-related apoptosis inducing ligand (TRAIL)-induced apoptosis for cancer chemoprevention,” European Journal of Cancer Prevention, vol. 20, no. 1, pp. 63–69, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. N. Kim, “Butein sensitizes human leukemia cells to apoptosis induced by tumor necrosis factor-related apoptosis inducing ligand (TRAIL),” Archives of Pharmacal Research, vol. 31, no. 9, pp. 1179–1186, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. E. Szliszka, Z. P. Czuba, B. Mazur, L. Sedek, A. Paradysz, and W. Krol, “Chalcones enhance TRAIL-induced apoptosis in prostate cancer cells,” International Journal of Molecular Sciences, vol. 11, no. 1, pp. 1–13, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. E. Szliszka, Z. P. Czuba, B. Mazur, A. Paradysz, and W. Krol, “Chalcones and dihydrochalcones augment TRAIL-mediated apoptosis in prostate cancer cells,” Molecules, vol. 15, no. 8, pp. 5336–5353, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. E. Szliszka, D. Jaworska, M. Ksek, Z. P. Czuba, and W. Król, “Targeting death receptor TRAIL-R2 by chalcones for TRAIL-induced apoptosis in cancer cells,” International Journal of Molecular Sciences, vol. 13, no. 11, pp. 15343–15359, 2012. View at Google Scholar
  47. T. Ohtsuki, H. Kikuchi, T. Koyano, T. Kowithayakorn, T. Sakai, and M. Ishibashi, “Death receptor 5 promoter-enhancing compounds isolated from Catimbium speciosum and their enhancement effect on TRAIL-induced apoptosis,” Bioorganic and Medicinal Chemistry, vol. 17, no. 18, pp. 6748–6754, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. T. Yoshida, M. Horinaka, M. Takara et al., “Combination of isoliquiritigenin and tumor necrosis factor-related apoptosis-inducing ligand induces apoptosis in colon cancer HT29 cells,” Environmental Health and Preventive Medicine, vol. 13, no. 5, pp. 281–287, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Desagher and J. C. Martinou, “Mitochondria as the central control point of apoptosis,” Trends in Cell Biology, vol. 10, no. 9, pp. 369–377, 2000. View at Publisher · View at Google Scholar · View at Scopus
  50. Y. F. Kuo, Y. Z. Su, Y. H. Tseng, S. Y. Wang, H. M. Wang, and P. J. Chueh, “Flavokawain B, a novel chalcone from Alpinia pricei Hayata with potent apoptotic activity: involvement of ROS and GADD153 upstream of mitochondria-dependent apoptosis in HCT116 cells,” Free Radical Biology and Medicine, vol. 49, no. 2, pp. 214–226, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. Y. Tang, X. Li, Z. Liu, A. R. Simoneau, J. Xie, and X. Zi, “Flavokawain B, a kava chalcone, induces apoptosis via up-regulation of death-receptor 5 and Bim expression in androgen receptor negative, hormonal refractory prostate cancer cell lines and reduces tumor growth,” International Journal of Cancer, vol. 127, no. 8, pp. 1758–1768, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. E. Lin, W. H. Lin, S. Y. Wang et al., “Flavokawain B inhibits growth of human squamous carcinoma cells: involvement of apoptosis and cell cycle dysregulation in vitro and in vivo,” Journal of Nutritional Biochemistry, vol. 23, no. 4, pp. 368–378, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. Y. Meng, J. Zhong, and H. Sun, “Effects of Ashitaba chalcone on caspase-3 and Bax protein expressions of mouse hepatocarcinoma cells,” Carcinogenesis, Teratogenesis and Mutagenesis, vol. 23, no. 1, pp. 50–53, 2011. View at Google Scholar
  54. C. L. Ye, F. Qian, D. Z. Wei, Y. H. Lu, and J. W. Liu, “Induction of apoptosis in K562 human leukemia cells by 2′,4′- dihydroxy-6′-methoxy-3′,5′-dimethylchalcone,” Leukemia Research, vol. 29, no. 8, pp. 887–892, 2005. View at Publisher · View at Google Scholar · View at Scopus
  55. J. I. Jung, S. S. Lim, H. J. Choi et al., “Isoliquiritigenin induces apoptosis by depolarizing mitochondrial membranes in prostate cancer cells,” Journal of Nutritional Biochemistry, vol. 17, no. 10, pp. 689–696, 2006. View at Publisher · View at Google Scholar · View at Scopus
  56. K. Motani, K. Tabata, Y. Kimura et al., “Proteomic analysis of apoptosis induced by xanthoangelol, a major constituent of Angelica keiskei, in neuroblastoma,” Biological and Pharmaceutical Bulletin, vol. 31, no. 4, pp. 618–626, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. N. M. Isa, A. B. Abdul, S. I. Abdelwahab et al., “Boesenbergin A, a chalcone from Boesenbergia rotunda induces apoptosis via mitochondrial dysregulation and cytochrome c release in A549 cells in vitro: involvement of HSP70 and Bcl2/Bax signalling pathways,” Journal of Functional Foods, vol. 5, no. 1, pp. 87–97, 2012. View at Google Scholar
  58. R. Nishimura, K. Tabata, M. Arakawa et al., “Isobavachalcone, a chalcone constituent of Angelica keiskei, induces apoptosis in neuroblastoma,” Biological and Pharmaceutical Bulletin, vol. 30, no. 10, pp. 1878–1883, 2007. View at Publisher · View at Google Scholar · View at Scopus
  59. L. Pan, H. Becker, and C. Gerhäuser, “Xanthohumol induces apoptosis in cultured 40-16 human colon cancer cells by activation of the death receptor- and mitochondrial pathway,” Molecular Nutrition and Food Research, vol. 49, no. 9, pp. 837–843, 2005. View at Publisher · View at Google Scholar · View at Scopus
  60. S. Kizaka-Kondoh, M. Inoue, H. Harada, and M. Hiraoka, “Tumor hypoxia: a target for selective cancer therapy,” Cancer Science, vol. 94, no. 12, pp. 1021–1028, 2003. View at Publisher · View at Google Scholar · View at Scopus
  61. P. Vaupel and A. Mayer, “Hypoxia in cancer: significance and impact on clinical outcome,” Cancer and Metastasis Reviews, vol. 26, no. 2, pp. 225–239, 2007. View at Publisher · View at Google Scholar · View at Scopus
  62. J. M. Brown and W. R. Wilson, “Exploiting tumour hypoxia in cancer treatment,” Nature Reviews Cancer, vol. 4, no. 6, pp. 437–447, 2004. View at Google Scholar · View at Scopus
  63. N. T. Dat, X. Jin, K. Lee, Y. S. Hong, Y. H. Kim, and J. J. Lee, “Hypoxia-inducible factor-1 inhibitory benzofurans and chalcone-derived Diels-Alder adducts from Morus species,” Journal of Natural Products, vol. 72, no. 1, pp. 39–43, 2009. View at Publisher · View at Google Scholar · View at Scopus
  64. B. Srinivasan, T. E. Johnson, and C. Xing, “Chalcone-based inhibitors against hypoxia-inducible factor 1: structure activity relationship studies,” Bioorganic and Medicinal Chemistry Letters, vol. 21, no. 1, pp. 555–557, 2011. View at Publisher · View at Google Scholar · View at Scopus
  65. K. Goto, T. Asai, S. Hara et al., “Enhanced antitumor activity of xanthohumol, a diacylglycerol acyltransferase inhibitor, under hypoxia,” Cancer Letters, vol. 219, no. 2, pp. 215–222, 2005. View at Publisher · View at Google Scholar · View at Scopus
  66. F. Mercurio and A. M. Manning, “Multiple signals converging on NF-κB,” Current Opinion in Cell Biology, vol. 11, no. 2, pp. 226–232, 1999. View at Publisher · View at Google Scholar · View at Scopus
  67. F. Mercurio, H. Zhu, B. W. Murray et al., “IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation,” Science, vol. 278, no. 5339, pp. 860–866, 1997. View at Publisher · View at Google Scholar · View at Scopus
  68. A. S. Baldwin, “Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB,” Journal of Clinical Investigation, vol. 107, no. 3, pp. 241–246, 2001. View at Google Scholar · View at Scopus
  69. M. K. Pandey, S. K. Sandur, B. Sung, G. Sethi, A. B. Kunnumakkara, and B. B. Aggarwal, “Butein, a tetrahydroxychalcone, inhibits nuclear factor (NF)-κB and NF-κB-regulated gene expression through direct inhibition of IκBα kinase β on cysteine 179 residue,” Journal of Biological Chemistry, vol. 282, no. 24, pp. 17340–17350, 2007. View at Publisher · View at Google Scholar · View at Scopus
  70. K. B. Harikumar, A. B. Kunnumakkara, K. S. Ahn et al., “Modification of the cysteine residues in IκBα kinase and NF-κB (p65) by xanthohumol leads to suppression of NF-κB-regulated gene products and potentiation of apoptosis in leukemia cells,” Blood, vol. 113, no. 9, pp. 2003–2013, 2009. View at Publisher · View at Google Scholar · View at Scopus
  71. C. Dorn, T. S. Weiss, J. Heilmann, and C. Hellerbrand, “Xanthohumol, a prenylated chalcone derived from hops, inhibits proliferation, migration and interleukin-8 expression of hepatocellular carcinoma cells,” International Journal of Oncology, vol. 36, no. 2, pp. 435–441, 2010. View at Publisher · View at Google Scholar · View at Scopus
  72. C. Dorn, T. S. Weiss, J. Heilmann, and C. Hellerbrand, “Inhibitory and apoptosis-inducing effects of xanthohumol, a prenylated chalone present in hops, in human prostate cancer cells,” Anticancer Research, vol. 30, no. 9, pp. 3333–3339, 2010. View at Google Scholar
  73. E. C. Colgate, C. L. Miranda, J. F. Stevens, T. M. Bray, and E. Ho, “Xanthohumol, a prenylflavonoid derived from hops induces apoptosis and inhibits NF-kappaB activation in prostate epithelial cells,” Cancer Letters, vol. 246, no. 1-2, pp. 201–209, 2007. View at Publisher · View at Google Scholar · View at Scopus
  74. S. C. Cheah, D. R. Appleton, S. T. Lee, M. L. Lam, A. H. A. Hadi, and M. R. Mustafa, “Panduratin a inhibits the growth of A549 cells through induction of apoptosis and inhibition of NF-KappaB translocation,” Molecules, vol. 16, no. 3, pp. 2583–2598, 2011. View at Publisher · View at Google Scholar · View at Scopus
  75. E. Cavalieri, D. Chakravarti, J. Guttenplan et al., “Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention,” Biochimica et Biophysica Acta, vol. 1766, no. 1, pp. 63–78, 2006. View at Publisher · View at Google Scholar · View at Scopus
  76. K. Mokbel, “The evolving role of aromatase inhibitors in breast cancer,” International Journal of Clinical Oncology, vol. 7, no. 5, pp. 279–283, 2002. View at Google Scholar · View at Scopus
  77. Y. Wang, F. L. Chan, S. Chen, and L. K. Leung, “The plant polyphenol butein inhibits testosterone-induced proliferation in breast cancer cells expressing aromatase,” Life Sciences, vol. 77, no. 1, pp. 39–51, 2005. View at Publisher · View at Google Scholar · View at Scopus
  78. M. Maggiolini, G. Statti, A. Vivacqua et al., “Estrogenic and antiproliferative activities of isoliquiritigenin in MCF7 breast cancer cells,” Journal of Steroid Biochemistry and Molecular Biology, vol. 82, no. 4-5, pp. 315–322, 2002. View at Publisher · View at Google Scholar · View at Scopus
  79. M. Baba, R. Asano, I. Takigami et al., “Studies on cancer chemoprevention by traditional folk medicines XXV. Inhibitory effect of isoliquiritigenin on azoxymethane-induced murine colon aberrant crypt focus formation and carcinogenesis,” Biological and Pharmaceutical Bulletin, vol. 25, no. 2, pp. 247–250, 2002. View at Publisher · View at Google Scholar · View at Scopus
  80. Y. W. Chin, H. A. Jung, Y. Liu et al., “Anti-oxidant constituents of the roots and stolons of licorice (Glycyrrhiza glabra),” Journal of Agricultural and Food Chemistry, vol. 55, no. 12, pp. 4691–4697, 2007. View at Publisher · View at Google Scholar · View at Scopus
  81. T. Takahashi, N. Takasuka, M. Iigo et al., “Isoliquiritigenin, a flavonoid from licorice, reduces prostaglandin E2 and nitric oxide, causes apoptosis, and suppresses aberrant crypt foci development,” Cancer Science, vol. 95, no. 5, pp. 448–453, 2004. View at Publisher · View at Google Scholar · View at Scopus
  82. M. Cuendet, J. Guo, Y. Luo et al., “Cancer chemopreventive activity and metabolism of isoliquiritigenin, a compound found in licorice,” Cancer Prevention Research, vol. 3, no. 2, pp. 221–232, 2010. View at Publisher · View at Google Scholar · View at Scopus
  83. B. Orlikova, D. Tasdemir, F. Golais, M. Dicato, and M. Diederich, “Dietary chalcones with chemopreventive and chemotherapeutic potential,” Genes and Nutrition, vol. 6, no. 2, pp. 125–147, 2011. View at Publisher · View at Google Scholar · View at Scopus
  84. T. Yokozawa, E. J. Cho, D. Y. Rhyu, N. Shibahara, and K. Aoyagi, “Glycyrrhizae Radix attenuates peroxynitrite-induced renal oxidative damage through inhibition of protein nitration,” Free Radical Research, vol. 39, no. 2, pp. 203–211, 2005. View at Publisher · View at Google Scholar · View at Scopus
  85. T. Akihisa, H. Tokuda, M. Ukiya et al., “Chalcones, coumarins, and flavanones from the exudate of Angelica keiskei and their chemopreventive effects,” Cancer Letters, vol. 201, no. 2, pp. 133–137, 2003. View at Publisher · View at Google Scholar · View at Scopus
  86. T. Akihisa, H. Tokuda, D. Hasegawa et al., “Chalcones and other compounds from the exudates of Angelica keiskei and their cancer chemopreventive effects,” Journal of Natural Products, vol. 69, no. 1, pp. 38–42, 2006. View at Publisher · View at Google Scholar · View at Scopus
  87. H. Matsuda, S. Kiyohara, S. Sugimoto, S. Ando, S. Nakamura, and M. Yoshikawa, “Bioactive constituents from Chinese natural medicines. XXXIII. Inhibitors from the seeds of Psoralea corylifolia on production of nitric oxide in lipopolysaccharide-activated macrophages,” Biological and Pharmaceutical Bulletin, vol. 32, no. 1, pp. 147–149, 2009. View at Publisher · View at Google Scholar · View at Scopus
  88. H. Haraguchi, J. Inoue, Y. Tamura, and K. Mizutani, “Antioxidative components of Psoralea corylifolia (Leguminosae),” Phytotherapy Research, vol. 16, no. 6, pp. 539–544, 2002. View at Publisher · View at Google Scholar · View at Scopus
  89. V. Kuete and L. P. Sandjo, “Isobavachalcone: an overview,” Chinese Journal of Integrative Medicine, vol. 18, no. 7, pp. 543–547, 2012. View at Google Scholar
  90. C. Gerhäuser, A. P. Alt, K. Klimo, J. Knauft, N. Frank, and H. Becker, “Isolation and potential cancer chemopreventive activities of phenolic compounds of beer,” Phytochemistry Reviews, vol. 1, no. 3, pp. 369–377, 2002. View at Publisher · View at Google Scholar · View at Scopus
  91. P. Kaur, S. Kaur, N. Kumar, B. Singh, and S. Kumar, “Evaluation of antigenotoxic activity of isoliquiritin apioside from Glycyrrhiza glabra L,” Toxicology in Vitro, vol. 23, no. 4, pp. 680–686, 2009. View at Publisher · View at Google Scholar · View at Scopus
  92. S. Monteghirfo, F. Tosetti, C. Ambrosini et al., “Antileukemia effects of xanthohumol in Bcr/Abl-transformed cells involve nuclear factor-κB and p53 modulation,” Molecular Cancer Therapeutics, vol. 7, no. 9, pp. 2692–2702, 2008. View at Publisher · View at Google Scholar · View at Scopus
  93. J. I. Jung, E. Chung, M. R. Seon et al., “Isoliquiritigenin (ISL) inhibits ErbB3 signaling in prostate cancer cells,” BioFactors, vol. 28, no. 3-4, pp. 159–168, 2006. View at Google Scholar · View at Scopus
  94. H. Jing, X. Zhou, X. Dong et al., “Abrogation of Akt signaling by Isobavachalcone contributes to its anti-proliferative effects towards human cancer cells,” Cancer Letters, vol. 294, no. 2, pp. 167–177, 2010. View at Publisher · View at Google Scholar · View at Scopus
  95. M. K. Pandey, S. Bokyung, S. A. Kwang, and B. B. Aggarwal, “Butein suppresses constitutive and inducible signal transducer and activator of transcription (stat) 3 activation and stat3-regulated gene products through the induction of a protein tyrosine phosphatase SHP-1,” Molecular Pharmacology, vol. 75, no. 3, pp. 525–533, 2009. View at Publisher · View at Google Scholar · View at Scopus
  96. T. Yagura, T. Motomiya, M. Ito et al., “Anticarcinogenic compounds in the Uzbek medicinal plant, Helichrysum maracandicum,” Journal of Natural Medicines, vol. 62, no. 2, pp. 174–178, 2008. View at Publisher · View at Google Scholar · View at Scopus
  97. A. M. Puebla-Perez, R. A. Herrera-Hernandez, M. M. Villasenor-Garcia et al., “Effect of isocordoin in the release of TGF-β1 of mice with L5178Y lymphoma,” in Proceedings of the 13th International Congress of Immunology, pp. 167–171, Rio de Janeiro, Brazil, 2007.
  98. S. Guerreiro, R. Monteiro, M. J. Martins, C. Calhau, I. Azevedo, and R. Soares, “Distinct modulation of alkaline phosphatase isoenzymes by 17β-estradiol and xanthohumol in breast cancer MCF-7 cells,” Clinical Biochemistry, vol. 40, no. 3-4, pp. 268–273, 2007. View at Publisher · View at Google Scholar · View at Scopus
  99. M. Mareel, M. Bracke, and F. Van Roy, “Invasion promoter versus invasion suppressor molecules: the paradigm of E-cadherin,” Molecular Biology Reports, vol. 19, no. 1, pp. 45–67, 1994. View at Google Scholar · View at Scopus
  100. C. Wittekind and M. Neid, “Cancer invasion and metastasis,” Oncology, vol. 69, supplement 1, pp. 14–16, 2005. View at Publisher · View at Google Scholar · View at Scopus
  101. B. Vanhoecke, L. Derycke, V. Van Marck, H. Depypere, D. De Keukeleire, and M. Bracke, “Antiinvasive effect of xanthohumol, a prenylated chalcone present in hops (Humulus lupulus L.) and beer,” International Journal of Cancer, vol. 117, no. 6, pp. 889–895, 2005. View at Publisher · View at Google Scholar · View at Scopus
  102. M. E. Bracke, B. W. A. Vanhoecke, L. Derycke et al., “Plant polyphenolics as anti-invasive cancer agents,” Anti-Cancer Agents in Medicinal Chemistry, vol. 8, no. 2, pp. 171–185, 2008. View at Publisher · View at Google Scholar · View at Scopus
  103. S. Lust, B. Vanhoecke, M. Van Gele et al., “Xanthohumol activates the proapoptotic arm of the unfolded protein response in chronic lymphocytic leukemia,” Anticancer Research, vol. 29, no. 10, pp. 3797–3805, 2009. View at Google Scholar · View at Scopus
  104. R. Benelli, R. Venè, M. Ciarlo, S. Carlone, O. Barbieri, and N. Ferrari, “The AKT/NF-κB inhibitor xanthohumol is a potent anti-lymphocytic leukemia drug overcoming chemoresistance and cell infiltration,” Biochemical Pharmacology, vol. 83, no. 12, pp. 1634–1642, 2012. View at Google Scholar
  105. B. Ngameni, M. Touaibia, R. Patnam et al., “Inhibition of MMP-2 secretion from brain tumor cells suggests chemopreventive properties of a furanocoumarin glycoside and of chalcones isolated from the twigs of Dorstenia turbinata,” Phytochemistry, vol. 67, no. 23, pp. 2573–2579, 2006. View at Publisher · View at Google Scholar · View at Scopus
  106. B. Ngameni, M. Touaibia, A. Belkaid et al., “Inhibition of matrix metalloproteinase-2 secretion by chalcones from the twigs of Dorstenia barteri Bureau,” Arkivoc, vol. 2007, no. 9, pp. 91–103, 2007. View at Google Scholar · View at Scopus
  107. Y. Kimura and K. Baba, “Antitumor and antimetastatic activities of Angelica keiskei roots, part 1: isolation of an active substance, xanthoangelol,” International Journal of Cancer, vol. 106, no. 3, pp. 429–437, 2003. View at Publisher · View at Google Scholar · View at Scopus
  108. Y. Kimura, M. Taniguchi, and K. Baba, “Antitumor and antimetastatic activities of 4-hydroxyderricin isolated from Angelica keiskei roots,” Planta Medica, vol. 70, no. 3, pp. 211–219, 2004. View at Publisher · View at Google Scholar · View at Scopus
  109. S. Yamazaki, T. Morita, H. Endo et al., “Isoliquiritigenin suppresses pulmonary metastasis of mouse renal cell carcinoma,” Cancer Letters, vol. 183, no. 1, pp. 23–30, 2002. View at Publisher · View at Google Scholar · View at Scopus
  110. S. Maddika, S. R. Ande, S. Panigrahi et al., “Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy,” Drug Resistance Updates, vol. 10, no. 1-2, pp. 13–29, 2007. View at Publisher · View at Google Scholar · View at Scopus
  111. J. M. Yun, M. H. Kweon, H. Kwon, J. K. Hwang, and H. Mukhtar, “Induction of apoptosis and cell cycle arrest by a chalcone panduratin A isolated from Kaempferia pandurata in androgen-independent human prostate cancer cells PC3 and DU145,” Carcinogenesis, vol. 27, no. 7, pp. 1454–1464, 2006. View at Publisher · View at Google Scholar · View at Scopus
  112. M. Kanazawa, Y. Satomi, Y. Mizutani et al., “Isoliquiritigenin inhibits the growth of prostate cancer,” European Urology, vol. 43, no. 5, pp. 580–586, 2003. View at Publisher · View at Google Scholar · View at Scopus
  113. G. S. Zhou, L. J. Song, and B. Yang, “Isoliquiritigenin inhibits proliferation and induces apoptosis of U87 human glioma cells in vitro,” Molecular Medicine Reports, vol. 7, no. 2, pp. 531–536, 2012. View at Google Scholar
  114. T. Ii, Y. Satomi, D. Katoh et al., “Induction of cell cycle arrest and p21CIP1/WAF1 expression in human lung cancer cells by isoliquiritigenin,” Cancer Letters, vol. 207, no. 1, pp. 27–35, 2004. View at Publisher · View at Google Scholar · View at Scopus
  115. Y. L. Hsu, P. L. Kuo, L. C. Chiang, and C. C. Lin, “Isoliquiritigenin inhibits the proliferation and induces the apoptosis of human non-small cell lung cancer A549 cells,” Clinical and Experimental Pharmacology and Physiology, vol. 31, no. 7, pp. 414–418, 2004. View at Publisher · View at Google Scholar · View at Scopus
  116. Y. L. Hsu, P. L. Kuo, and C. C. Lin, “Isoliquiritigenin induces apoptosis and cell cycle arrest through p53-dependent pathway in Hep G2 cells,” Life Sciences, vol. 77, no. 3, pp. 279–292, 2005. View at Publisher · View at Google Scholar · View at Scopus
  117. Y. K. Rao, S. H. Fang, and Y. M. Tzeng, “Differential effects of synthesized 2′-oxygenated chalcone derivatives: modulation of human cell cycle phase distribution,” Bioorganic and Medicinal Chemistry, vol. 12, no. 10, pp. 2679–2686, 2004. View at Publisher · View at Google Scholar · View at Scopus
  118. Y. K. Rao, T. Y. Kao, J. L. Ko, and Y. M. Tzeng, “Chalcone HTMC causes in vitro selective cytotoxicity, cell-cycle G 1 phase arrest through p53-dependent pathway in human lung adenocarcinoma A549 cells, and in vivo tumor growth suppression,” Bioorganic and Medicinal Chemistry Letters, vol. 20, no. 22, pp. 6508–6512, 2010. View at Publisher · View at Google Scholar · View at Scopus
  119. Y. Fu, T. C. Hsieh, J. Guo et al., “Licochalcone-A, a novel flavonoid isolated from licorice root (Glycyrrhiza glabra), causes G2 and late-G1 arrests in androgen-independent PC-3 prostate cancer cells,” Biochemical and Biophysical Research Communications, vol. 322, no. 1, pp. 263–270, 2004. View at Publisher · View at Google Scholar · View at Scopus
  120. X. F. Zhu, B. F. Xie, J. M. Zhou et al., “Blockade of vascular endothelial growth factor receptor signal pathway and antitumor activity of ON-III (2′,4′-dihydroxy-6′-methoxy- 3′,5′-dimethylchalcone), a component from Chinese herbal medicine,” Molecular Pharmacology, vol. 67, no. 5, pp. 1444–1450, 2005. View at Publisher · View at Google Scholar · View at Scopus
  121. J. Mojzis, L. Varinska, G. Mojzisova, I. Kostova, and L. Mirossay, “Antiangiogenic effects of flavonoids and chalcones,” Pharmacological Research, vol. 57, no. 4, pp. 259–265, 2008. View at Publisher · View at Google Scholar · View at Scopus
  122. C. Gerhäuser, “Beer constituents as potential cancer chemopreventive agents,” European Journal of Cancer, vol. 41, no. 13, pp. 1941–1954, 2005. View at Publisher · View at Google Scholar · View at Scopus
  123. A. Albini, R. Dell'Eva, R. Vené et al., “Mechanisms of the antiangiogenic activity by the hop flavonoid xanthohumol: NF-κB and Akt as targets,” FASEB Journal, vol. 20, no. 3, pp. 527–529, 2006. View at Publisher · View at Google Scholar · View at Scopus
  124. R. Dell'Eva, C. Ambrosini, N. Vannini, G. Piaggio, A. Albini, and N. Ferrari, “AKT/NF-κB inhibitor xanthohumol targets cell growth and angiogenesis in hematologic malignancies,” Cancer, vol. 110, no. 9, pp. 2007–2011, 2007. View at Publisher · View at Google Scholar · View at Scopus
  125. R. Negrão, J. Incio, R. Lopes, I. Azevedo, and R. Soares, “Evidence for the effects of xanthohumol in disrupting angiogenic, but not stable vessels,” International Journal of Biomedical Science, vol. 3, no. 4, pp. 279–286, 2007. View at Google Scholar
  126. D. Li, Z. Wang, H. Chen et al., “Isoliquiritigenin induces monocytic differentiation of HL-60 cells,” Free Radical Biology and Medicine, vol. 46, no. 6, pp. 731–736, 2009. View at Publisher · View at Google Scholar · View at Scopus
  127. C. K. Lee, S. H. Son, K. K. Park, J. H. Y. Park, S. S. Lim, and W. Y. Chung, “Isoliquiritigenin inhibits tumor growth and protects the kidney and liver against chemotherapy-induced toxicity in a mouse xenograft model of colon carcinoma,” Journal of Pharmacological Sciences, vol. 106, no. 3, pp. 444–451, 2008. View at Publisher · View at Google Scholar · View at Scopus
  128. M. Samoszuk, J. Tan, and G. Chorn, “The chalcone butein from Rhus verniciflua Stokes inhibits clonogenic growth of human breast cancer cells co-cultured with fibroblasts,” BMC Complementary and Alternative Medicine, vol. 5, article 5, 2005. View at Publisher · View at Google Scholar · View at Scopus
  129. H. Nozaki, K. I. Hayashi, M. Kido et al., “Pauferrol A, a novel chalcone trimer with a cyclobutane ring from Caesalpinia ferrea mart exhibiting DNA topoisomerase II inhibition and apoptosis-inducing activity,” Tetrahedron Letters, vol. 48, no. 47, pp. 8290–8292, 2007. View at Publisher · View at Google Scholar · View at Scopus
  130. P. Krishnan and K. F. Bastow, “Novel mechanism of cellular DNA topoisomerase II inhibition by the pyranonaphthoquinone derivatives α-lapachone and β-lapachone,” Cancer Chemotherapy and Pharmacology, vol. 47, no. 3, pp. 187–198, 2001. View at Publisher · View at Google Scholar · View at Scopus